跳至主要内容
临床试验/JPRN-UMIN000023329
JPRN-UMIN000023329已完成未知

Retrospective cohort study for assessment of association between imaging changes and outcome after treatment of regorafenib(KSCC1603) - Retrospective cohort study for assessment of imaging changes after use of regorafenib

Kyushu Study group of Clinical Cancer0 个研究点目标入组 200 人开始时间: 2016年7月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with active double cancer. Carcinoma in situ (intraepithelial carcinoma) or the intramucosal carcinoma equivalent lesion which are concurrent double cancers and heterochronous double cancers within five years of progression free, and the investigator judged to cure by topical treatment, are excluded as the double cancer. 2. Any other patients who are regarded as unsuitable for this study by the investigators.

研究者

发起方
Kyushu Study group of Clinical Cancer

相似试验

Retrospective cohort study for assessment of... | 临床试验